BRPI0419105A - usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno - Google Patents
usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofilenoInfo
- Publication number
- BRPI0419105A BRPI0419105A BRPI0419105-6A BRPI0419105A BRPI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A
- Authority
- BR
- Brazil
- Prior art keywords
- karyophyllenes
- inflammatory
- compositions
- composition
- karyophyllene
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010065390 Inflammatory pain Diseases 0.000 title abstract 2
- 230000004968 inflammatory condition Effects 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2004/000189 WO2006037194A1 (en) | 2004-10-01 | 2004-10-01 | Use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0419105B1 BRPI0419105B1 (pt) | 2006-04-13 |
| BRPI0419105A true BRPI0419105A (pt) | 2007-12-11 |
| BRPI0419105B8 BRPI0419105B8 (pt) | 2021-05-25 |
Family
ID=36142256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR122016029094-8A BR122016029094B1 (pt) | 2004-10-01 | 2004-10-01 | Composição farmacêutica anti-inflamatória |
| BRPI0419105-6A BRPI0419105A (pt) | 2004-10-01 | 2004-10-01 | usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR122016029094-8A BR122016029094B1 (pt) | 2004-10-01 | 2004-10-01 | Composição farmacêutica anti-inflamatória |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080280996A1 (pt) |
| EP (1) | EP1809268B1 (pt) |
| JP (1) | JP2008514649A (pt) |
| AR (1) | AR048806A1 (pt) |
| AT (1) | ATE518531T1 (pt) |
| BR (2) | BR122016029094B1 (pt) |
| CA (1) | CA2577219A1 (pt) |
| MX (1) | MX2007002116A (pt) |
| WO (1) | WO2006037194A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007066305A1 (en) * | 2005-12-09 | 2007-06-14 | Zelpy 2549 (Pty) Limited | Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain |
| CA2688570A1 (en) * | 2007-05-31 | 2008-12-04 | F.P.L. Pharma Inc. | Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| JP2012077002A (ja) * | 2010-09-30 | 2012-04-19 | Oita Univ | ATL及びHTLV−1関連炎症疾患をターゲットとしたNF−κB亢進抑制剤及びその用途 |
| JP6326563B2 (ja) * | 2012-03-19 | 2018-05-23 | アリエル−ユニバーシティー リサーチ アンド デベロップメント カンパニー リミテッド | β−カリオフィレンとCB2受容体アゴニストを用いた精神病の治療 |
| KR101477552B1 (ko) * | 2012-12-07 | 2014-12-30 | 세명대학교 산학협력단 | 유제놀 유도체를 함유하는 아토피성 피부염의 치료용 약제학적 조성물 및 그 제조방법 |
| BR112017018944A2 (pt) | 2015-03-02 | 2018-05-15 | Afgin Pharma, Llc | método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s) |
| US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
| US10039740B2 (en) * | 2015-10-23 | 2018-08-07 | Primus Pharmaceuticals, Inc. | Therapeutic combinations of sesquiterpenes and flavonoids |
| US10456365B2 (en) * | 2016-03-25 | 2019-10-29 | Primus Pharmaceuticals, Inc. | Methods and formulations for supporting and promoting bone health |
| US20180049994A1 (en) * | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
| WO2018033891A1 (en) * | 2016-08-19 | 2018-02-22 | Aurea Biolabs Private Limited | An anti-inflammatory composition for the treatment of acute joint inflammation and a process for preparation thereof |
| KR102043893B1 (ko) * | 2018-01-05 | 2019-11-12 | 인제대학교 산학협력단 | 알파-휴물렌(alpha-Humulene)을 유효성분으로 포함하는 소화기계 점막 관련 질환 예방 또는 치료용 조성물 |
| KR102040810B1 (ko) | 2018-01-31 | 2019-11-05 | 인제대학교 산학협력단 | 알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3987008A (en) | 1971-12-17 | 1976-10-19 | Celanese Corporation | Flame retardant polyester |
| NL9100688A (nl) | 1991-04-19 | 1992-11-16 | Tno | Toepassing van terpenoide verbindingen in de land- of tuinbouw alsmede voor de bereiding van preparaten voor het bestrijden van witte vliegsoorten. |
| US5314693A (en) | 1992-02-07 | 1994-05-24 | Kioritz Corporation | Pest control chemicals against pine wood nematodes |
| JPH07215846A (ja) * | 1994-01-28 | 1995-08-15 | Takeda Chem Ind Ltd | 抗アレルギー剤 |
| CA2342403A1 (en) | 2001-03-28 | 2002-09-28 | Jean Legault | Sesquiterpene derivatives as anticancer agents |
| US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| CA2356438A1 (en) * | 2001-09-05 | 2003-03-05 | Andre Pichette | Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers |
| US20060241130A1 (en) * | 2003-01-31 | 2006-10-26 | Ehud Keinan | Anti-inflammatory compositions and uses thereof |
| JP2005206520A (ja) * | 2004-01-22 | 2005-08-04 | Univ Kinki | アテローム性動脈硬化抑制剤ならびにこれを含む食品および医薬 |
-
2004
- 2004-10-01 BR BR122016029094-8A patent/BR122016029094B1/pt active IP Right Grant
- 2004-10-01 MX MX2007002116A patent/MX2007002116A/es not_active Application Discontinuation
- 2004-10-01 EP EP04761549A patent/EP1809268B1/en not_active Expired - Lifetime
- 2004-10-01 US US11/576,351 patent/US20080280996A1/en not_active Abandoned
- 2004-10-01 AT AT04761549T patent/ATE518531T1/de not_active IP Right Cessation
- 2004-10-01 CA CA002577219A patent/CA2577219A1/en not_active Abandoned
- 2004-10-01 BR BRPI0419105-6A patent/BRPI0419105A/pt active IP Right Grant
- 2004-10-01 WO PCT/BR2004/000189 patent/WO2006037194A1/en not_active Ceased
- 2004-10-01 JP JP2007533830A patent/JP2008514649A/ja active Pending
- 2004-11-29 AR ARP040104416A patent/AR048806A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1809268A1 (en) | 2007-07-25 |
| BRPI0419105B1 (pt) | 2006-04-13 |
| BR122016029094B1 (pt) | 2021-10-13 |
| US20080280996A1 (en) | 2008-11-13 |
| BRPI0419105B8 (pt) | 2021-05-25 |
| WO2006037194A1 (en) | 2006-04-13 |
| EP1809268B1 (en) | 2011-08-03 |
| MX2007002116A (es) | 2007-10-16 |
| AR048806A1 (es) | 2006-05-31 |
| ATE518531T1 (de) | 2011-08-15 |
| JP2008514649A (ja) | 2008-05-08 |
| CA2577219A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1420801T3 (da) | Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis | |
| BRPI0713288A2 (pt) | composiÇÕes de limpeza e/ou de tratamento que compreendem alfa-amilases mutantes | |
| PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
| IS2882B (is) | Samsetning epóþílonhliðstæðna og virkra efna til efnameðferðar til þess að meðhöndla frumufjölgunarsjúkdóma | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| EA201001865A1 (ru) | Противовоспалительные агенты | |
| WO2006024018A3 (en) | Compositions for treating nociceptive pain | |
| BRPI0516483A (pt) | preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade | |
| BR0304648A (pt) | Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| DK1429756T3 (da) | Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer | |
| WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
| DK1648484T3 (da) | Fremgangsmåde til behandling af arthritis-tilstande | |
| DK1758860T3 (da) | Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande | |
| BR112022001390A2 (pt) | Inibidores de enzima | |
| WO2007005720A3 (en) | Methods and compositions for promoting wound healing | |
| BRPI0711885A2 (pt) | Aminotiazóis e seus usos | |
| WO2008057158A3 (en) | Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications | |
| WO2007059154A3 (en) | Treatment of cancers with acquired resistance to kit inhibitors | |
| DK1919466T3 (da) | Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat | |
| FI20000635A0 (fi) | COMT-inhibiittoreiden käyttö analgeettina | |
| TW200716088A (en) | Formulations and methods for treating amyloidosis | |
| BRPI0414724A (pt) | combinação, composição farmacêutica, métodos para prevenir ou tratar aterosclerose em um animal de sangue quente e para prevenir eventos cardiovasculares em um animal de sangue quente, e, kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2326 DE 04/08/2015. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07C | Technical examination (opinion): republication [chapter 7.3 patent gazette] |
Free format text: REF. RPI 2378 DE 02/08/2016, DEVIDO A INCORRECAO NA JUNTADA, EM FORMATO DIGITAL, DOS DOCUMENTOS ENCAMINHADOS PELA ANVISA. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: "INPI NO 52402.007437/2022-69 ORIGEM: 7A VARA CIVEL FEDERAL DE SAO PAULO PROCESSO NO: 5003067-27.2022.4.03.6101 SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: LUIZ FRANCISCO PIANOWSKI REU(S): ACHE LABOTATORIOS FARMACEUTICOS S/A E INSTITUTONACIONAL DA PROPRIEDADE INTELECTUAL" |